Clinical practice guidelines for the management of dyslipidemia
- PMID: 15230023
Clinical practice guidelines for the management of dyslipidemia
Abstract
The causal relationship between dyslipidemia and atherosclerosis is well-documented. Screening and appropriate management of dyslipidemia by health care providers is imperative in both primary and secondary prevention of coronary artery disease, peripheral vascular disease, and stroke. In response to the release of new research data, clinical practice guidelines for the management of dyslipidemia in Canada have recently been updated. This article will provide an overview of the recommendations for screening, risk assessment, and target lipid values. Dietary and lifestyle interventions will be discussed in addition to pharmacotherapy as management strategies for achieving therapeutic lipid targets.
Similar articles
-
Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update.CMAJ. 2003 Oct 28;169(9):921-4. CMAJ. 2003. PMID: 14581310 Free PMC article. No abstract available.
-
Identification and management of vascular risk: beyond low density lipoprotein cholesterol.AAOHN J. 2003 Dec;51(12):521-31; quiz 532-3. AAOHN J. 2003. PMID: 14680155 Review.
-
Reducing CVD risk - integration of clinical and laboratory criteria.Aust Fam Physician. 2008 Jun;37(6):422-7. Aust Fam Physician. 2008. PMID: 18523695 Review.
-
Quality of cholesterol screening and management with respect to the National Cholesterol Education's Third Adult Treatment Panel (ATPIII) guideline in primary care practices in North Carolina.Am Heart J. 2006 Oct;152(4):785-92. doi: 10.1016/j.ahj.2006.04.017. Am Heart J. 2006. PMID: 16996859
-
Clinical inquiries. What is the best strategy for monitoring the lipid-lowering effects of medical therapy used for the primary prevention of coronary artery disease (CAD)?J Fam Pract. 2001 Nov;50(11):928. J Fam Pract. 2001. PMID: 11711006 Review. No abstract available.